Sharechat Logo

Serko lifts guidance range for 2019 revenue on Flight Centre negotiations

Tuesday 31st July 2018

Text too small?

Serko, the online travel booking software developer, has lifted its 2019 revenue expectation slightly due to a planned extension of its partnership with Flight Centre Travel Group.

Its guidance range is now for revenue growth between 20 and 30 percent in 2019 from 2018's $18.3 million, compared to earlier guidance of 15 to 30 percent growth. In previous guidance, Serko has said it doesn't expect growth in earnings before interest, tax, depreciation and amortisation from 2018's $2.2 million, due to the cost of its expansion in Europe and North America.

Flight Centre and Serko will now negotiate a contract variation, which they intend to be effective by Sept. 1, which would see Flight Centre's brands across Australia, New Zealand and Asia use Serko software until at least April 2022, and its technology also used in the US, Canada and Mexico. Flight Centre will also pay an "ongoing development contribution" to Serko until at least April 2019, prompting the guidance upgrade. 

Serko said that if a binding contract variation is agreed, it expects the relationship with Flight Centre to lift revenue in 2020 as well, and it will give a further update at its annual meeting on August 22.

The shares last traded at $2.75, and have gained 26 percent this year.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors